{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:58:45Z","timestamp":1792126725606,"version":"4.4.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s12276-019-0216-4","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T06:03:08Z","timestamp":1551074588000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["Disturbed homocysteine metabolism is associated with cancer"],"prefix":"10.1038","volume":"51","author":[{"given":"Tauheed","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetika","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket Kumar","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshmee","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurumayum Suraj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laishram Rajendrakumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"216_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0140-6736(64)92852-1","volume":"1","author":"L Mcdonald","year":"1964","unstructured":"Mcdonald, L., Bary, C., Field, C., Love, F. & Davies, B. Homocystinuria, thrombosis, and the blood-platelets. Lancet 1, 745\u2013746 (1964).","journal-title":"Lancet"},{"key":"216_CR2","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.bbagen.2015.08.013","volume":"1850","author":"GS Sharma","year":"2015","unstructured":"Sharma, G. S., Kumar, T., Dar, T. A. & Singh, L. R. Protein N-homocysteinylation: from cellular toxicity to neurodegeneration. Biochim. Biophys. Acta 1850, 2239\u20132245 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"216_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0753-3322(02)00242-1","volume":"56","author":"M Morganti","year":"2002","unstructured":"Morganti, M. et al. Atherosclerosis and cancer: common pathways on the vascular endothelium. Biomed. Pharmacother. 56, 317\u2013324 (2002).","journal-title":"Biomed. Pharmacother."},{"key":"216_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0100-879X2009007500021","volume":"43","author":"S Brustolin","year":"2010","unstructured":"Brustolin, S., Giugliani, R. & F\u00e9lix, T. M. Genetics of homocysteine metabolism and associated disorders. Braz. J. Med. Biol. Res. 43, 1\u20137 (2010).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"216_CR5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/91.6.535","volume":"91","author":"RZ Stolzenberg-Solomon","year":"1999","unstructured":"Stolzenberg-Solomon, R. Z. et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J. Natl. Cancer Inst. 91, 535\u2013541 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"216_CR6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri, S. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N. Engl. J. Med. 346, 476\u2013483 (2002).","journal-title":"N. Engl. J. Med."},{"key":"216_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(02)02702-3","volume":"518","author":"SB Vafai","year":"2002","unstructured":"Vafai, S. B. & Stock, J. B. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer\u2019s Disease. FEBS Lett. 518, 1\u20134 (2002).","journal-title":"FEBS Lett."},{"key":"216_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/00365510500453003","volume":"66","author":"E Ruud","year":"2006","unstructured":"Ruud, E., Holmstr\u00f8m, H., Brosstad, F. & Wesenberg, F. Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis. Scand. J. Clin. Lab. Invest. 66, 67\u201378 (2006).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"216_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/JGP.0b013e3181f17eed","volume":"19","author":"RCM Ho","year":"2011","unstructured":"Ho, R. C. M. et al. Is high homocysteine level a risk factor for cognitive decline in elderly? a systematic review, meta-analysis, and meta-regression. Am. J. Geriatr. Psychiatry 19, 607\u2013617 (2011).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"216_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson, M. P. & Shea, T. B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137\u2013146 (2003).","journal-title":"Trends Neurosci."},{"key":"216_CR11","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid, R. & Herrmann, W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580, 2994\u20133005 (2006).","journal-title":"FEBS Lett."},{"key":"216_CR12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2006-9404","volume":"9","author":"S Seshadri","year":"2006","unstructured":"Seshadri, S. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer\u2019s disease? J. Alzheimers Dis. 9, 393\u2013398 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"216_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/87.4.265","volume":"87","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci, E. et al. Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J. Natl. Cancer Inst. 87, 265\u2013273 (1995).","journal-title":"J. Natl. Cancer Inst."},{"key":"216_CR14","first-page":"825","volume":"8","author":"J Ma","year":"1999","unstructured":"Ma, J. et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol. Biomark. Prev. 8, 825\u2013829 (1999).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/09637486.2014.959896","volume":"66","author":"V Bravat\u00e0","year":"2015","unstructured":"Bravat\u00e0, V. Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease. Int. J. Food Sci. Nutr. 66, 43\u201349 (2015).","journal-title":"Int. J. Food Sci. Nutr."},{"key":"216_CR16","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/sj.bjc.6690305","volume":"79","author":"I Kato","year":"1999","unstructured":"Kato, I. et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case\u2013control study. Br. J. Cancer 79, 1917\u20131921 (1999).","journal-title":"Br. J. Cancer"},{"key":"216_CR17","first-page":"1332","volume":"11","author":"MM Jong de","year":"2002","unstructured":"de Jong, M. M. et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 11, 1332\u20131352 (2002).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR18","first-page":"353","volume":"3","author":"K Matsuo","year":"2002","unstructured":"Matsuo, K. et al. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac. J. Cancer Prev. 3, 353\u2013359 (2002).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"216_CR19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/aje\/kwg024","volume":"157","author":"K Robien","year":"2003","unstructured":"Robien, K. & Ulrich, C. M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am. J. Epidemiol. 157, 571\u2013582 (2003).","journal-title":"Am. J. Epidemiol."},{"key":"216_CR20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood-2003-06-1794","volume":"103","author":"M Krajinovic","year":"2004","unstructured":"Krajinovic, M. et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103, 252\u2013257 (2004).","journal-title":"Blood"},{"key":"216_CR21","first-page":"1465","volume":"25","author":"R Singal","year":"2004","unstructured":"Singal, R., Ferdinand, L., Das, P. M., Reis, I. M. & Schlesselman, J. J. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int. J. Oncol. 25, 1465\u20131471 (2004).","journal-title":"Int. J. Oncol."},{"key":"216_CR22","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/carcin\/bgi196","volume":"26","author":"K Matsuo","year":"2005","unstructured":"Matsuo, K. et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 26, 2164\u20132171 (2005).","journal-title":"Carcinogenesis"},{"key":"216_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbabio.2009.03.005","volume":"1787","author":"D Mancardi","year":"2009","unstructured":"Mancardi, D. et al. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim. Biophys. Acta 1787, 864\u2013872 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"216_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-8981(02)00174-2","volume":"322","author":"LL Wu","year":"2002","unstructured":"Wu, L. L. & Wu, J. T. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin. Chim. Acta 322, 21\u201328 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"216_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00043798-199808000-00003","volume":"5","author":"JM Scott","year":"1998","unstructured":"Scott, J. M. & Weir, D. G. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J. Cardiovasc. Risk 5, 223\u2013227 (1998).","journal-title":"J. Cardiovasc. Risk"},{"key":"216_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","volume":"19","author":"J Selhub","year":"1999","unstructured":"Selhub, J. Homocysteine metabolism. Annu. Rev. Nutr. 19, 217\u2013246 (1999).","journal-title":"Annu. Rev. Nutr."},{"key":"216_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","volume":"93","author":"PF Jacques","year":"1996","unstructured":"Jacques, P. F. et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7\u20139 (1996).","journal-title":"Circulation"},{"key":"216_CR28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1096\/fj.02-0456fje","volume":"17","author":"BC Schwahn","year":"2003","unstructured":"Schwahn, B. C. et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 17, 512\u2013514 (2003).","journal-title":"FASEB J."},{"key":"216_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jn\/137.2.311","volume":"137","author":"KT Williams","year":"2007","unstructured":"Williams, K. T. & Schalinske, K. L. New insights into the regulation of methyl group and homocysteine metabolism. J. Nutr. 137, 311\u2013314 (2007).","journal-title":"J. Nutr."},{"key":"216_CR30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale, J. W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572\u2013583 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"216_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jnci\/95.5.373","volume":"95","author":"SM Zhang","year":"2003","unstructured":"Zhang, S. M. et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J. Natl. Cancer Inst. 95, 373\u2013380 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"216_CR32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2005.05.013","volume":"52","author":"A Siniscalchi","year":"2005","unstructured":"Siniscalchi, A. et al. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol. Res. 52, 367\u2013375 (2005).","journal-title":"Pharmacol. Res."},{"key":"216_CR33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ajcn\/28.4.371","volume":"28","author":"JL Smith","year":"1975","unstructured":"Smith, J. L., Goldsmith, G. A. & Lawrence, J. D. Effects of oral contraceptive steroids on vitamin and lipid levels in serum. Am. J. Clin. Nutr. 28, 371\u2013376 (1975).","journal-title":"Am. J. Clin. Nutr."},{"key":"216_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/026010608300200105","volume":"2","author":"ECG Grant","year":"1983","unstructured":"Grant, E. C. G. The contraceptive pill: its relation to allergy and illness. Nutr. Health 2, 33\u201340 (1983).","journal-title":"Nutr. Health"},{"key":"216_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0010-7824(84)90102-1","volume":"30","author":"K Amatayakul","year":"1984","unstructured":"Amatayakul, K., Uttaravichai, C., Singkamani, R. & Ruckphaopunt, S. Vitamin metabolism and the effects of multivitamin supplementation in oral contraceptive users. Contraception 30, 179\u2013196 (1984).","journal-title":"Contraception"},{"key":"216_CR36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00016348509154689","volume":"64","author":"K Hjelt","year":"1985","unstructured":"Hjelt, K., Brynskov, J., Hippe, E., Lundstr\u00f6m, P. & Munck, O. Oral contraceptives and the cobalamin (Vitamin B 12) metabolism. Acta Obstet. Gynecol. Scand. 64, 59\u201363 (1985).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"216_CR37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/humupd\/5.1.64","volume":"5","author":"R Obwegeser","year":"1999","unstructured":"Obwegeser, R., Hohlagschwandtner, M. & Sinzinger, H. Homocysteine-a pathophysiological cornerstone in obstetrical and gynaecological disorders? Hum. Reprod. Update 5, 64\u201372 (1999).","journal-title":"Hum. Reprod. Update"},{"key":"216_CR38","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/bi00482a004","volume":"29","author":"WR Montfort","year":"1990","unstructured":"Montfort, W. R. et al. Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry 29, 6964\u20136977 (1990).","journal-title":"Biochemistry"},{"key":"216_CR39","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"BC Blount","year":"1997","unstructured":"Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA 94, 3290\u20133295 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR40","unstructured":"Hay, R. K. M., Park, J.-G. & Gazdar, A. Atlas of Human Tumor Cell Lines. (Elsevier Science, Amsterdam, 1994)."},{"key":"216_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"KS Crider","year":"2012","unstructured":"Crider, K. S., Yang, T. P., Berry, R. J. & Bailey, L. B. Folate and DNA methylation: a review of molecular mechanisms and the evidence for Folate\u2019s role. Adv. Nutr. 3, 21\u201338 (2012).","journal-title":"Adv. Nutr."},{"key":"216_CR42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10577-012-9297-9","volume":"20","author":"LE Hall","year":"2012","unstructured":"Hall, L. E., Mitchell, S. E. & O\u2019Neill, R. J. Pericentric and centromeric transcription: a perfect balance required. Chromosom. Res. 20, 535\u2013546 (2012).","journal-title":"Chromosom. Res."},{"key":"216_CR43","doi-asserted-by":"crossref","first-page":"2424S","DOI":"10.1093\/jn\/132.8.2424S","volume":"132","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich, M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J. Nutr. 132, 2424S\u20132429S (2002).","journal-title":"J. Nutr."},{"key":"216_CR44","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene 21, 5400\u20135413 (2002).","journal-title":"Oncogene"},{"key":"216_CR45","doi-asserted-by":"crossref","first-page":"e0123423","DOI":"10.1371\/journal.pone.0123423","volume":"10","author":"D Zhang","year":"2015","unstructured":"Zhang, D., Wen, X., Wu, W., Guo, Y. & Cui, W. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PLoS ONE 10, e0123423 (2015).","journal-title":"PLoS ONE"},{"key":"216_CR46","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1200\/JCO.2002.08.135","volume":"20","author":"A Stathopoulou","year":"2002","unstructured":"Stathopoulou, A. et al. Molecular detection of cytokeratin-19\u2013positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J. Clin. Oncol. 20, 3404\u20133412 (2002).","journal-title":"J. Clin. Oncol."},{"key":"216_CR47","doi-asserted-by":"crossref","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","volume":"136","author":"H Refsum","year":"2006","unstructured":"Refsum, H. et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 136, 1731S\u20131740S (2006).","journal-title":"J. Nutr."},{"key":"216_CR48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0009-8981(02)00092-X","volume":"321","author":"CF Sun","year":"2002","unstructured":"Sun, C.-F., Haven, T. R., Wu, T.-L., Tsao, K.-C. & Wu, J. T. Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin. Chim. Acta 321, 55\u201362 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"216_CR49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00394-004-0446-6","volume":"43","author":"B Akoglu","year":"2004","unstructured":"Akoglu, B., Milovic, V., Caspary, W. F. & Faust, D. Hyperproliferation of homocysteinetreated colon cancer cells is reversed by folate and 5-methyltetrahydrofolate. Eur. J. Nutr. 43, 93\u201399 (2004).","journal-title":"Eur. J. Nutr."},{"key":"216_CR50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01307180","volume":"11","author":"FR Rickles","year":"1992","unstructured":"Rickles, F. R., Levine, M. & Edwards, R. L. Hemostatic alterations in cancer patients. Cancer Metastas-. Rev. 11, 237\u2013248 (1992).","journal-title":"Cancer Metastas-. Rev."},{"key":"216_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1751-553X.2007.00907.x","volume":"29","author":"A GATT","year":"2007","unstructured":"GATT, A. et al. Hyperhomocysteinemia in women with advanced breast cancer. Int. J. Lab. Hematol. 29, 421\u2013425 (2007).","journal-title":"Int. J. Lab. Hematol."},{"key":"216_CR52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8588(05)70349-X","volume":"10","author":"KB Green","year":"1996","unstructured":"Green, K. B. & Silverstein, R. L. Hypercoagulability in cancer. Hematol. Oncol. Clin. North Am. 10, 499\u2013530 (1996).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"216_CR53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","volume":"162","author":"JA Heit","year":"2002","unstructured":"Heit, J. A. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch. Intern. Med. 162, 1245\u20131248 (2002).","journal-title":"Arch. Intern. Med."},{"key":"216_CR54","first-page":"47","volume":"88","author":"A Kakkar","year":"2001","unstructured":"Kakkar, A., Haas, S., Walsh, D. & Encke, A. Prevention of perioperative venous thromboembolism: outcome after cancer and noncancer surgery. Br. J. Surg. 88, 47 (2001).","journal-title":"Br. J. Surg."},{"key":"216_CR55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1096-7192(03)00008-8","volume":"78","author":"H Zhu","year":"2003","unstructured":"Zhu, H. et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol. Genet. Metab. 78, 216\u2013221 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"216_CR56","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch, G. N. & Loscalzo, J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338, 1042\u20131050 (1998).","journal-title":"N. Engl. J. Med."},{"key":"216_CR57","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2174\/1871527313666140917121943","volume":"13","author":"RK Chowhan","year":"2014","unstructured":"Chowhan, R. K., Mittal, S., Dar, T. A., Kamal, M. A. & Singh, L. R. Ignored avenues in alpha-synuclein associated proteopathy. CNS Neurol. Disord. Drug Targets 13, 1246\u20131257 (2014).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"216_CR58","doi-asserted-by":"crossref","first-page":"e116386","DOI":"10.1371\/journal.pone.0116386","volume":"9","author":"GS Sharma","year":"2014","unstructured":"Sharma, G. S., Kumar, T. & Singh, L. R. N-homocysteinylation induces different structural and functional consequences on acidic and basic proteins. PLoS ONE 9, e116386 (2014).","journal-title":"PLoS ONE"},{"key":"216_CR59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cca.2016.04.002","volume":"458","author":"T Kumar","year":"2016","unstructured":"Kumar, T., Sharma, G. S. & Singh, L. R. Homocystinuria: therapeutic approach. Clin. Chim. Acta 458, 55\u201362 (2016).","journal-title":"Clin. Chim. Acta"},{"key":"216_CR60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI118771","volume":"98","author":"SR Lentz","year":"1996","unstructured":"Lentz, S. R. et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst (e) inemia. J. Clin. Invest. 98, 24\u201329 (1996).","journal-title":"J. Clin. Invest."},{"key":"216_CR61","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","volume":"99","author":"NV Chandrasekharan","year":"2002","unstructured":"Chandrasekharan, N. V. et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: Cloning, structure, and expression. Proc. Natl Acad. Sci. USA 99, 13926\u201313931 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(03)12560-3","volume":"361","author":"GA FitzGerald","year":"2003","unstructured":"FitzGerald, G. A. Parsing an enigma: the pharmacodynamics of aspirin resistance. Lancet 361, 542\u2013544 (2003).","journal-title":"Lancet"},{"key":"216_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0694-195","volume":"7","author":"P Goyette","year":"1994","unstructured":"Goyette, P. et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat. Genet. 7, 195\u2013200 (1994).","journal-title":"Nat. Genet."},{"key":"216_CR64","first-page":"1052","volume":"56","author":"P Goyette","year":"1995","unstructured":"Goyette, P., Frosst, P., Rosenblatt, D. S. & Rozen, R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype\/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet 56, 1052\u20131059 (1995).","journal-title":"Am. J. Hum. Genet"},{"key":"216_CR65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.ejhg.5200182","volume":"6","author":"LA Kluijtmans","year":"1998","unstructured":"Kluijtmans, L. A. et al. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur. J. Hum. Genet. 6, 257\u2013265 (1998).","journal-title":"Eur. J. Hum. Genet."},{"key":"216_CR66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg, I., Tran, P., Christensen, B., Sibani, S. & Rozen, R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64, 169\u2013172 (1998).","journal-title":"Mol. Genet. Metab."},{"key":"216_CR67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<280::AID-HUMU9>3.0.CO;2-I","volume":"15","author":"S Sibani","year":"2000","unstructured":"Sibani, S. et al. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Hum. Mutat. 15, 280\u2013287 (2000).","journal-title":"Hum. Mutat."},{"key":"216_CR68","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1023\/A:1013988123902","volume":"24","author":"C Tonetti","year":"2001","unstructured":"Tonetti, C., Amiel, J., Munnich, A. & Zittoun, J. Impact of new mutations in the methylenetetrahydrofolate reductase gene assessed on biochemical phenotypes: a familial study. J. Inherit. Metab. Dis. 24, 833\u2013842 (2001).","journal-title":"J. Inherit. Metab. Dis."},{"key":"216_CR69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/aje\/kwh066","volume":"159","author":"L Sharp","year":"2004","unstructured":"Sharp, L. & Little, J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 159, 423\u2013443 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"216_CR70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10048-004-0177-0","volume":"5","author":"H Yano","year":"2004","unstructured":"Yano, H. et al. Mutations of the MTHFR gene (428C\u2009>\u2009T and [458G\u2009>\u2009T\u2009+\u2009459C\u2009>\u2009T]) markedly decrease MTHFR enzyme activity. Neurogenetics 5, 135\u2013140 (2004).","journal-title":"Neurogenetics"},{"key":"216_CR71","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(95)91743-8","volume":"346","author":"NM Put van der","year":"1995","unstructured":"van der Put, N. M. et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346, 1070\u20131071 (1995).","journal-title":"Lancet"},{"key":"216_CR72","first-page":"35","volume":"58","author":"LA Kluijtmans","year":"1996","unstructured":"Kluijtmans, L. A. et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58, 35\u201341 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"216_CR73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5455\/msm.2013.25.170-174","volume":"25","author":"J Brezovska-Kavrakova","year":"2013","unstructured":"Brezovska-Kavrakova, J. et al. Hyperhomocysteinemia and of methylenetetrahydrofolate reductase (C677T) genetic polymorphism in patients with deep vein thrombosis. Mater. Sociomed. 25, 170\u2013174 (2013).","journal-title":"Mater. Sociomed."},{"key":"216_CR74","unstructured":"mthfr - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=mthfr . Accessed 14 November 2018."},{"key":"216_CR75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111\u2013113 (1995).","journal-title":"Nat. Genet."},{"key":"216_CR76","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(00)00671-7","volume":"156","author":"IS Weisberg","year":"2001","unstructured":"Weisberg, I. S. et al. The 1298A--\u2009>\u2009C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 156, 409\u2013415 (2001).","journal-title":"Atherosclerosis"},{"key":"216_CR77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2125.2009.03556.x","volume":"69","author":"MC Etienne-Grimaldi","year":"2010","unstructured":"Etienne-Grimaldi, M.-C. et al. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients. Br. J. Clin. Pharmacol. 69, 58\u201366 (2010).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"216_CR78","first-page":"1098","volume":"57","author":"J Ma","year":"1997","unstructured":"Ma, J. et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57, 1098\u20131102 (1997).","journal-title":"Cancer Res."},{"key":"216_CR79","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/pros.21200","volume":"70","author":"MR Safarinejad","year":"2010","unstructured":"Safarinejad, M. R., Shafiei, N. & Safarinejad, S. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study. Prostate 70, 1645\u20131657 (2010).","journal-title":"Prostate"},{"key":"216_CR80","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/carcin\/18.12.2307","volume":"18","author":"M Esteller","year":"1997","unstructured":"Esteller, M., Garcia, A., Martinez-Palones, J. M., Xercavins, J. & Reventos, J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18, 2307\u20132311 (1997).","journal-title":"Carcinogenesis"},{"key":"216_CR81","first-page":"3272","volume":"61","author":"C Song","year":"2001","unstructured":"Song, C., Xing, D., Tan, W., Wei, Q. & Lin, D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 61, 3272\u20133275 (2001).","journal-title":"Cancer Res."},{"key":"216_CR82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.cej.0000186640.19872.4d","volume":"15","author":"BR Guelpen Van","year":"2006","unstructured":"Van Guelpen, B. R. et al. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur. J. Cancer Prev. 15, 46\u201350 (2006).","journal-title":"Eur. J. Cancer Prev."},{"key":"216_CR83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1055-9965.EPI-07-0657","volume":"17","author":"M Johansson","year":"2008","unstructured":"Johansson, M. et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition Study. Cancer Epidemiol. Biomark. Prev. 17, 279\u2013285 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/01635580902846593","volume":"61","author":"J Shannon","year":"2009","unstructured":"Shannon, J. et al. Folate intake and prostate cancer risk: a case-control study. Nutr. Cancer 61, 617\u2013628 (2009).","journal-title":"Nutr. Cancer"},{"key":"216_CR85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(99)00412-7","volume":"151","author":"T Marugame","year":"2000","unstructured":"Marugame, T. et al. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett. 151, 181\u2013186 (2000).","journal-title":"Cancer Lett."},{"key":"216_CR86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/14622416.3.3.299","volume":"3","author":"CM Ulrich","year":"2002","unstructured":"Ulrich, C. M., Robien, K. & Sparks, R. Pharmacogenetics and folate metabolism\u2014a promising direction. Pharmacogenomics 3, 299\u2013313 (2002).","journal-title":"Pharmacogenomics"},{"key":"216_CR87","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1073\/pnas.96.22.12810","volume":"96","author":"CF Skibola","year":"1999","unstructured":"Skibola, C. F. et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl Acad. Sci. USA 96, 12810\u201312815 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR88","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/carcin\/bgm089","volume":"28","author":"K Curtin","year":"2007","unstructured":"Curtin, K. et al. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28, 1672\u20131679 (2007).","journal-title":"Carcinogenesis"},{"key":"216_CR89","unstructured":"mtrr - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=mtrr . Accessed 14 November 2018."},{"key":"216_CR90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/mgme.1999.2879","volume":"67","author":"A Wilson","year":"1999","unstructured":"Wilson, A. et al. A common variant in methionine synthase reductase combined with low cobalamin (Vitamin B12) increases risk for spina bifida. Mol. Genet. Metab. 67, 317\u2013323 (1999).","journal-title":"Mol. Genet. Metab."},{"key":"216_CR91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(02)00204-6","volume":"166","author":"PF Jacques","year":"2003","unstructured":"Jacques, P. F. et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 166, 49\u201355 (2003).","journal-title":"Atherosclerosis"},{"key":"216_CR92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1126\/science.2579435","volume":"228","author":"SE Goelz","year":"1985","unstructured":"Goelz, S. E., Vogelstein, B., Hamilton, S. R. & Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187\u2013190 (1985).","journal-title":"Science"},{"key":"216_CR93","first-page":"761","volume":"9","author":"AJ Alberg","year":"2000","unstructured":"Alberg, A. J. et al. The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiol. Biomark. Prev. 9, 761\u2013764 (2000).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR94","doi-asserted-by":"crossref","first-page":"2960S","DOI":"10.1093\/jn\/135.12.2960S","volume":"135","author":"HJ Powers","year":"2005","unstructured":"Powers, H. J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J. Nutr. 135, 2960S\u20132966S (2005).","journal-title":"J. Nutr."},{"key":"216_CR95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1399-0004.2006.00618.x","volume":"69","author":"A Mostowska","year":"2006","unstructured":"Mostowska, A., Hozyasz, K. & Jagodzinski, P. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin. Genet. 69, 512\u2013517 (2006).","journal-title":"Clin. Genet."},{"key":"216_CR96","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ajcn\/83.4.895","volume":"83","author":"RZ Stolzenberg-Solomon","year":"2006","unstructured":"Stolzenberg-Solomon, R. Z. et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Clin. Nutr. 83, 895\u2013904 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"216_CR97","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ejca.2009.05.013","volume":"45","author":"V Charasson","year":"2009","unstructured":"Charasson, V. et al. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model. Eur. J. Cancer 45, 2391\u20132401 (2009).","journal-title":"Eur. J. Cancer"},{"key":"216_CR98","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00432-007-0301-2","volume":"134","author":"N Ott","year":"2008","unstructured":"Ott, N., Geddert, H. & Sarbia, M. Polymorphisms in methionine synthase (A2756G) and cystathionine-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J. Cancer Res Clin. Oncol. 134, 405\u2013410 (2008).","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"216_CR99","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/1055-9965.EPI-08-0916","volume":"18","author":"M Hua Tao","year":"2009","unstructured":"Hua Tao, M. et al. Null results in brief DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol. Biomark. Prev. 18, 998\u20131002 (2009).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR100","unstructured":"mthfd - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=mthfd . Accessed 14 November 2018"},{"key":"216_CR101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.a.30354","volume":"132A","author":"A Parle-McDermott","year":"2005","unstructured":"Parle-McDermott, A. et al. MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am. J. Med. Genet. Part A 132A, 365\u2013368 (2005).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"216_CR102","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1078-0432.CCR-06-2293","volume":"13","author":"L Wang","year":"2007","unstructured":"Wang, L. et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin. Cancer Res. 13, 2526\u20132532 (2007).","journal-title":"Clin. Cancer Res."},{"key":"216_CR103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0004.1998.tb02658.x","volume":"53","author":"FA Hol","year":"2008","unstructured":"Hol, F. A. et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin. Genet. 53, 119\u2013125 (2008).","journal-title":"Clin. Genet."},{"key":"216_CR104","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/gtmb.2013.0171","volume":"17","author":"V Sulzyc-Bielicka","year":"2013","unstructured":"Sulzyc-Bielicka, V. et al. Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil. Genet. Test. Mol. Biomark. 17, 799\u2013806 (2013).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"216_CR105","unstructured":"tyms - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=tyms . Accessed 14 November 2018."},{"key":"216_CR106","first-page":"3249","volume":"19","author":"K Kawakami","year":"1999","unstructured":"Kawakami, K., . & Omura, K. & Kanehira, E. & Watanabe, Y. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.Anticancer. Res. 19, 3249\u20133252 (1999).","journal-title":"Anticancer. Res."},{"key":"216_CR107","unstructured":"tcn II - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=tcn+II . Accessed 14 November 2018."},{"key":"216_CR108","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3945\/ajcn.117.156349","volume":"106","author":"A Oussalah","year":"2017","unstructured":"Oussalah, A., Levy, J., Filhine-Tr\u00e9sarrieu, P., Namour, F. & Gu\u00e9ant, J.-L. Association of TCN2 rs1801198 c.776G---\u2009>\u2009C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies. Am. J. Clin. Nutr. 106, 1142\u20131156 (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"216_CR109","unstructured":"bhmt - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=bhmt . Accessed 14 November 2018."},{"key":"216_CR110","unstructured":"cbs - SNP - NCBI. Available at: https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=cbs . Accessed 14 November 2018."},{"key":"216_CR111","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1096\/fj.07-101279","volume":"22","author":"X Xu","year":"2008","unstructured":"Xu, X. et al. Choline metabolism and risk of breast cancer in a population-based study. FASEB J. 22, 2045\u20132052 (2008).","journal-title":"FASEB J."},{"key":"216_CR112","doi-asserted-by":"crossref","first-page":"34588","DOI":"10.1074\/jbc.M805928200","volume":"283","author":"T Majtan","year":"2008","unstructured":"Majtan, T., Singh, L. R., Wang, L., Kruger, W. D. & Kraus, J. P. Active cystathionine \u03b2-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J. Biol. Chem. 283, 34588\u201334595 (2008).","journal-title":"J. Biol. Chem."},{"key":"216_CR113","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","volume":"171","author":"C Szabo","year":"2014","unstructured":"Szabo, C. et al. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br. J. Pharmacol. 171, 2099\u20132122 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"216_CR114","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","volume":"6","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917\u2013935 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"216_CR115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1476-5381.2010.01191.x","volume":"164","author":"C Szab\u00f3","year":"2011","unstructured":"Szab\u00f3, C. & Papapetropoulos, A. Hydrogen sulphide and angiogenesis: mechanisms and applications. Br. J. Pharmacol. 164, 853\u2013865 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"216_CR116","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110267","volume":"121","author":"M Whiteman","year":"2011","unstructured":"Whiteman, M., Le Trionnaire, S., Chopra, M., Fox, B. & Whatmore, J. Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools. Clin. Sci. 121, 459\u2013488 (2011).","journal-title":"Clin. Sci."},{"key":"216_CR117","doi-asserted-by":"crossref","first-page":"013","DOI":"10.1385\/MN:26:1:013","volume":"26","author":"H Kimura","year":"2002","unstructured":"Kimura, H. Hydrogen sulfide as a neuromodulator. Mol. Neurobiol. 26, 013\u2013020 (2002).","journal-title":"Mol. Neurobiol."},{"key":"216_CR118","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2005.07.060","volume":"129","author":"S Fiorucci","year":"2005","unstructured":"Fiorucci, S. et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129, 1210\u20131224 (2005).","journal-title":"Gastroenterology"},{"key":"216_CR119","doi-asserted-by":"crossref","first-page":"483.e1","DOI":"10.1016\/j.urology.2011.10.013","volume":"79","author":"H Guo","year":"2012","unstructured":"Guo, H. et al. Characterization of hydrogen sulfide and its synthases, cystathionine \u03b2-Synthase and cystathionine \u03b3-Lyase, in human prostatic tissue and cells. Urology 79, 483.e1\u2013483.e5 (2012).","journal-title":"Urology"},{"key":"216_CR120","doi-asserted-by":"crossref","first-page":"e79167","DOI":"10.1371\/journal.pone.0079167","volume":"8","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya, S. et al. Cystathionine beta-synthase (cbs) contributes to advanced ovarian cancer progression and drug resistance. PLoS ONE 8, e79167 (2013).","journal-title":"PLoS ONE"},{"key":"216_CR121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2016.08.026","volume":"113","author":"A Katsouda","year":"2016","unstructured":"Katsouda, A., Bibli, S.-I., Pyriochou, A., Szabo, C. & Papapetropoulos, A. Regulation and role of endogenously produced hydrogen sulfide in angiogenesis. Pharmacol. Res. 113, 175\u2013185 (2016).","journal-title":"Pharmacol. Res."},{"key":"216_CR122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","volume":"230","author":"MR Hellmich","year":"2015","unstructured":"Hellmich, M. R. & Szabo, C. Hydrogen sulfide and cancer. Handb. Exp. Pharmacol. 230, 233\u2013241 (2015).","journal-title":"Handb. Exp. Pharmacol."},{"key":"216_CR123","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/bph.12368","volume":"171","author":"K M\u00f3dis","year":"2014","unstructured":"M\u00f3dis, K. et al. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br. J. Pharmacol. 171, 2123\u20132146 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"216_CR124","doi-asserted-by":"crossref","first-page":"22457","DOI":"10.1074\/jbc.M109.010868","volume":"284","author":"S Singh","year":"2009","unstructured":"Singh, S., Padovani, D., Leslie, R. A., Chiku, T. & Banerjee, R. Relative contributions of cystathionine \u03b2-Synthase and \u03b3-Cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J. Biol. Chem. 284, 22457\u201322466 (2009).","journal-title":"J. Biol. Chem."},{"key":"216_CR125","first-page":"1077","volume":"7","author":"LR Winkler","year":"2016","unstructured":"Winkler, L. R. et al. Population structure and genotype\u2013phenotype associations in a collection of oat landraces and historic cultivars. Front. Plant Sci. 7, 1077 (2016).","journal-title":"Front. Plant Sci."},{"key":"216_CR126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.niox.2014.03.001","volume":"41","author":"K M\u00f3dis","year":"2014","unstructured":"M\u00f3dis, K. et al. Effect of S-adenosyl-l-methionine (SAM), an allosteric activator of cystathionine-\u03b2-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide 41, 146\u2013156 (2014).","journal-title":"Nitric Oxide"},{"key":"216_CR127","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2007.04.011","volume":"91","author":"LR Singh","year":"2007","unstructured":"Singh, L. R., Chen, X., Ko\u017eich, V. & Kruger, W. D. Chemical chaperone rescue of mutant human cystathionine \u03b2-synthase. Mol. Genet. Metab. 91, 335\u2013342 (2007).","journal-title":"Mol. Genet. Metab."},{"key":"216_CR128","doi-asserted-by":"crossref","first-page":"20958","DOI":"10.1073\/pnas.1011448107","volume":"107","author":"M Koutmos","year":"2010","unstructured":"Koutmos, M., Kabil, O., Smith, J. L. & Banerjee, R. Structural basis for substrate activation and regulation by cystathionine beta-synthase (CBS) domains in cystathionine -synthase. Proc. Natl Acad. Sci. USA 107, 20958\u201320963 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR129","doi-asserted-by":"crossref","first-page":"e1000807","DOI":"10.1371\/journal.pgen.1000807","volume":"6","author":"LR Singh","year":"2010","unstructured":"Singh, L. R., Gupta, S., Honig, N. H., Kraus, J. P. & Kruger, W. D. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet. 6, e1000807 (2010).","journal-title":"PLoS Genet."},{"key":"216_CR130","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/01.ATV.20.7.1704","volume":"20","author":"SH Mudd","year":"2000","unstructured":"Mudd, S. H. et al. Homocysteine and its disulfide derivatives. Arterioscler. Thromb. Vasc. Biol. 20, 1704\u20131706 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"216_CR131","first-page":"1","volume":"37","author":"SH Mudd","year":"1985","unstructured":"Mudd, S. H. et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Hum. Genet 37, 1\u201331 (1985).","journal-title":"Am. J. Hum. Genet"},{"key":"216_CR132","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI108350","volume":"57","author":"DE Wilcken","year":"1976","unstructured":"Wilcken, D. E. & Wilcken, B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest. 57, 1079\u20131082 (1976).","journal-title":"J. Clin. Invest."},{"key":"216_CR133","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI8342","volume":"106","author":"RT Eberhardt","year":"2000","unstructured":"Eberhardt, R. T. et al. Endothelial dysfunction in a murine model of mild hyperhomocyst (e) inemia. J. Clin. Invest. 106, 483\u2013491 (2000).","journal-title":"J. Clin. Invest."},{"key":"216_CR134","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.53.6.731","volume":"53","author":"LA Harker","year":"1983","unstructured":"Harker, L. A., Harlan, J. M. & Ross, R. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ. Res. 53, 731\u2013739 (1983).","journal-title":"Circ. Res."},{"key":"216_CR135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","volume":"80","author":"P Quadri","year":"2004","unstructured":"Quadri, P. et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80, 114\u2013122 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"216_CR136","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000032550.90046.38","volume":"33","author":"SP McIlroy","year":"2002","unstructured":"McIlroy, S. P., Dynan, K. B., Lawson, J. T., Patterson, C. C. & Passmore, A. P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33, 2351\u20132356 (2002).","journal-title":"Stroke"},{"key":"216_CR137","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1073\/pnas.93.26.15227","volume":"93","author":"TH Rosenquist","year":"1996","unstructured":"Rosenquist, T. H., Ratashak, S. A. & Selhub, J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc. Natl Acad. Sci. USA 93, 15227\u201315232 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"216_CR138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ajcn\/81.1.147","volume":"81","author":"CA Hobbs","year":"2005","unstructured":"Hobbs, C. A., Cleves, M. A., Melnyk, S., Zhao, W. & James, S. J. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am. J. Clin. Nutr. 81, 147\u2013153 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"216_CR139","doi-asserted-by":"crossref","first-page":"369S","DOI":"10.1093\/jn\/130.2.369S","volume":"130","author":"IF McDowell","year":"2000","unstructured":"McDowell, I. F. & Lang, D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J. Nutr. 130, 369S\u2013372S (2000).","journal-title":"J. Nutr."},{"key":"216_CR140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","volume":"49","author":"H Refsum","year":"1998","unstructured":"Refsum, H., Ueland, P. M., Nygard, O. & Vollset, S. E. Homocysteine and cardiovascular disease. Annu Rev. Med 49, 31\u201362 (1998).","journal-title":"Annu Rev. Med"},{"key":"216_CR141","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2007.01.028","volume":"257","author":"E Martignoni","year":"2007","unstructured":"Martignoni, E. et al. Homocysteine and Parkinson\u2019s disease: a dangerous liaison? J. Neurol. Sci. 257, 31\u201337 (2007).","journal-title":"J. Neurol. Sci."},{"key":"216_CR142","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","volume":"20","author":"P Lamberti","year":"2005","unstructured":"Lamberti, P. et al. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson\u2019s disease patients. Mov. Disord. 20, 69\u201372 (2005).","journal-title":"Mov. Disord."},{"key":"216_CR143","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","volume":"8","author":"AA Moustafa","year":"2014","unstructured":"Moustafa, A. A., Hewedi, D. H., Eissa, A. M., Frydecka, D. & Misiak, B. Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front. Behav. Neurosci. 8, 343 (2014).","journal-title":"Front. Behav. Neurosci."},{"key":"216_CR144","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","volume":"11","author":"JW Muntjewerff","year":"2006","unstructured":"Muntjewerff, J.-W., Kahn, R. S., Blom, H. J. & den Heijer, M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11, 143 (2006).","journal-title":"Mol. Psychiatry"},{"key":"216_CR145","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s007020070010","volume":"107","author":"F Leblhuber","year":"2000","unstructured":"Leblhuber, F. et al. Hyperhomocysteinemia in dementia. J. Neural Transm. 107, 1469\u20131474 (2000).","journal-title":"J. Neural Transm."},{"key":"216_CR146","doi-asserted-by":"crossref","unstructured":"Shea, T. B. & Rogers, E. Homocysteine and dementia. N Engl J Med 346, 2007\u20132008 (2002).","DOI":"10.1056\/NEJM200206203462514"},{"key":"216_CR147","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.159.12.2099","volume":"159","author":"H Tiemeier","year":"2002","unstructured":"Tiemeier, H. et al. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am. J. Psychiatry 159, 2099\u20132101 (2002).","journal-title":"Am. J. Psychiatry"},{"key":"216_CR148","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archpsyc.65.11.1286","volume":"65","author":"OP Almeida","year":"2008","unstructured":"Almeida, O. P. et al. Homocysteine and depression in later life. Arch. Gen. Psychiatry 65, 1286\u20131294 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"key":"216_CR149","first-page":"319","volume":"58","author":"A Janula","year":"2005","unstructured":"Janula, A. et al. Homocysteine and diabetes. Wiad. Lek. (Wars., Pol. 1960) 58, 319\u2013323 (2005).","journal-title":"Wiad. Lek. (Wars., Pol. 1960)"},{"key":"216_CR150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4158\/EP.6.6.435","volume":"6","author":"BS Baliga","year":"2000","unstructured":"Baliga, B. S., Reynolds, T., Fink, L. M. & Fonseca, V. A. Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine. Endocr. Pract. 6, 435\u2013441 (2000).","journal-title":"Endocr. Pract."},{"key":"216_CR151","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp.2004.039875","volume":"76","author":"JL Gueant","year":"2005","unstructured":"Gueant, J. L. et al. Homocysteine and related genetic polymorphisms in Down\u2019s syndrome IQ. J. Neurol. Neurosurg. Psychiatry 76, 706\u2013709 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"216_CR152","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM198403153101104","volume":"310","author":"S Schuh","year":"1984","unstructured":"Schuh, S. et al. Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N. Engl. J. Med 310, 686\u2013690 (1984).","journal-title":"N. Engl. J. Med"},{"key":"216_CR153","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<253::AID-TERA4>3.0.CO;2-V","volume":"60","author":"WY Wong","year":"1999","unstructured":"Wong, W. Y. et al. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 60, 253\u2013257 (1999).","journal-title":"Teratology"},{"key":"216_CR154","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1302\/0301-620X.54B2.277","volume":"54","author":"DP Brenton","year":"1972","unstructured":"Brenton, D. P., Dow, C. J., James, J. I. P., Hay, R. L. & Wynne-Davies, R. Homocystinuria and Marfan\u2019s syndrome. Bone Jt. J. 54, 277\u2013298 (1972).","journal-title":"Bone Jt. J."},{"key":"216_CR155","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1055-9965.1088.13.6","volume":"13","author":"RA Paynter","year":"2004","unstructured":"Paynter, R. A., Hankinson, S. E., Hunter, D. J. & De Vivo, I. No association between MTHFR 677 C->T or 1298 A---\u2009>\u2009C polymorphisms and endometrial cancer risk. Cancer Epidemiol. Biomark. Prev. 13, 1088\u20131089 (2004).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR156","first-page":"693","volume":"29","author":"Y Shujuan","year":"2013","unstructured":"Shujuan, Y., Jianxing, Z. & Xin-Yue, C. Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Pak. J. Med. Sci. 29, 693\u2013698 (2013).","journal-title":"Pak. J. Med. Sci."},{"key":"216_CR157","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/OTT.S121472","volume":"10","author":"L He","year":"2017","unstructured":"He, L. & Shen, Y. MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls. Onco. Targets Ther. 10, 227\u2013238 (2017).","journal-title":"Onco. Targets Ther."},{"key":"216_CR158","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/pcan.2012.5","volume":"15","author":"XL Li","year":"2012","unstructured":"Li, X.-L. & Xu, J.-H. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case\u2013control studies. Prostate Cancer Prostatic Dis. 15, 244\u2013249 (2012).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"216_CR159","first-page":"4862","volume":"56","author":"J Chen","year":"1996","unstructured":"Chen, J. et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56, 4862\u20134864 (1996).","journal-title":"Cancer Res."},{"key":"216_CR160","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/carcin\/19.12.2129","volume":"19","author":"J Chen","year":"1998","unstructured":"Chen, J. et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19, 2129\u20132132 (1998).","journal-title":"Carcinogenesis"},{"key":"216_CR161","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1158\/1055-9965.2175.13.12","volume":"13","author":"A Ulvik","year":"2004","unstructured":"Ulvik, A. et al. Colorectal cancer and the methylenetetrahydrofolate reductase 677C ---\u2009>\u2009T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol. Biomark. Prev. 13, 2175\u20132180 (2004).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR162","doi-asserted-by":"crossref","first-page":"e88823","DOI":"10.1371\/journal.pone.0088823","volume":"9","author":"YT Qin","year":"2014","unstructured":"Qin, Y.-T. et al. Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis. PLoS ONE 9, e88823 (2014).","journal-title":"PLoS ONE"},{"key":"216_CR163","first-page":"659","volume":"9","author":"MM Haghighi","year":"2008","unstructured":"Haghighi, M. M. et al. Association between the 1793G----\u2009>\u2009A MTHFR polymorphism and sporadic colorectal cancer in Iran. Asian Pac. J. Cancer Prev. 9, 659\u2013662 (2008).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"216_CR164","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3109\/10428194.2013.867492","volume":"55","author":"DH Fang","year":"2014","unstructured":"Fang, D.-H., Ji, Q., Fan, C.-H., An, Q. & Li, J. Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies. Leuk. Lymphoma 55, 1910\u20131914 (2014).","journal-title":"Leuk. Lymphoma"},{"key":"216_CR165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7150\/jca.17379","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang, P., Li, S., Wang, M., He, J. & Xi, S. Association of MTRR A66G polymorphism with cancer susceptibility: evidence from 85 studies. J. Cancer 8, 266\u2013277 (2017).","journal-title":"J. Cancer"},{"key":"216_CR166","first-page":"918","volume":"20","author":"PP Wu","year":"2015","unstructured":"Wu, P.-P., Tang, R.-N. & An, L. A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility. J. Buon. 20, 918\u2013922 (2015).","journal-title":"J. Buon."},{"key":"216_CR167","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/j.canep.2012.05.016","volume":"36","author":"LJ Yuan","year":"2012","unstructured":"Yuan, L. J. et al. Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population. Cancer Epidemiol. 36, e366\u2013e372 (2012).","journal-title":"Cancer Epidemiol."},{"key":"216_CR168","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5808\/GI.2012.10.3.184","volume":"10","author":"JY Yoo","year":"2012","unstructured":"Yoo, J.-Y. et al. Association study between folate pathway gene single nucleotide polymorphisms and gastric cancer in Koreans. Genom. Inform. 10, 184\u2013193 (2012).","journal-title":"Genom. Inform."},{"key":"216_CR169","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1897-4287-12-2","volume":"12","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in chinese women. Hered. Cancer Clin. Pract. 12, 2 (2014).","journal-title":"Hered. Cancer Clin. Pract."},{"key":"216_CR170","doi-asserted-by":"crossref","first-page":"e61511","DOI":"10.1371\/journal.pone.0061511","volume":"8","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 39327 subjects. PLoS ONE 8, e61511 (2013).","journal-title":"PLoS ONE"},{"key":"216_CR171","first-page":"429","volume":"28","author":"K Chen","year":"2006","unstructured":"Chen, K. et al. Association between genetic polymorphisms in folate metabolic enzyme genes and colorectal cancer: a nested case-control study. Zhonghua Zhong Liu Za Zhi 28, 429\u2013432 (2006).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"216_CR172","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.fpc.0000170916.96650.70","volume":"15","author":"Q Shi","year":"2005","unstructured":"Shi, Q. et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharm. Genom. 15, 547\u2013555 (2005).","journal-title":"Pharm. Genom."},{"key":"216_CR173","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s12032-011-0066-y","volume":"29","author":"LH Cui","year":"2012","unstructured":"Cui, L.-H. et al. Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Med. Oncol. 29, 1837\u20131842 (2012).","journal-title":"Med. Oncol."},{"key":"216_CR174","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/1055-9965.EPI-05-0979","volume":"15","author":"A Semmler","year":"2006","unstructured":"Semmler, A., Simon, M., Moskau, S. & Linnebank, M. The methionine synthase polymorphism c.2756A----\u2009>\u2009G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol. Biomark. Prev. 15, 2314\u20132316 (2006).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/1055-9965.EPI-06-0513","volume":"16","author":"FF Zhang","year":"2007","unstructured":"Zhang, F. F. et al. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol. Biomark. Prev. 16, 115\u2013121 (2007).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR176","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1158\/1055-9965.EPI-08-0470","volume":"17","author":"T Suzuki","year":"2008","unstructured":"Suzuki, T. et al. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol. Biomark. Prev. 17, 2742\u20132747 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR177","doi-asserted-by":"crossref","first-page":"e69366","DOI":"10.1371\/journal.pone.0069366","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang, H., Ma, H., Li, L., Zhang, Z. & Xu, Y. Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis. PLoS ONE 8, e69366 (2013).","journal-title":"PLoS ONE"},{"key":"216_CR178","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s13277-013-1446-z","volume":"35","author":"Y Cui","year":"2014","unstructured":"Cui, Y., Jing, Y. & Sun, Z. Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility. Tumor Biol. 35, 3385\u20133389 (2014).","journal-title":"Tumor Biol."},{"key":"216_CR179","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11033-011-0813-3","volume":"39","author":"LMRB Silva da","year":"2012","unstructured":"da Silva, L. M. R. B. et al. MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk. Mol. Biol. Rep. 39, 887\u2013893 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"216_CR180","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1055-9965.EPI-07-2900","volume":"17","author":"X Xu","year":"2008","unstructured":"Xu, X. et al. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol. Biomark. Prev. 17, 2109\u20132116 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR181","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinbiochem.2011.02.007","volume":"44","author":"A Mostowska","year":"2011","unstructured":"Mostowska, A., Myka, M., Lianeri, M., Roszak, A. & Jagodzi\u0144ski, P. P. Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin. Biochem. 44, 596\u2013600 (2011).","journal-title":"Clin. Biochem."},{"key":"216_CR182","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1007\/s11033-011-1359-0","volume":"39","author":"P Pawlik","year":"2012","unstructured":"Pawlik, P. et al. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population. Mol. Biol. Rep. 39, 5553\u20135560 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"216_CR183","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/carcin\/bgm062","volume":"28","author":"A Hazra","year":"2007","unstructured":"Hazra, A. et al. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses\u2019 Health Study. Carcinogenesis 28, 1510\u20131519 (2007).","journal-title":"Carcinogenesis"},{"key":"216_CR184","doi-asserted-by":"crossref","first-page":"e109235","DOI":"10.1371\/journal.pone.0109235","volume":"9","author":"SC Chang","year":"2014","unstructured":"Chang, S.-C. et al. Single nucleotide polymorphisms of one-carbon metabolism and cancers of the esophagus, stomach, and liver in a Chinese population. PLoS ONE 9, e109235 (2014).","journal-title":"PLoS ONE"},{"key":"216_CR185","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/1055-9965.EPI-06-0624","volume":"15","author":"A Koushik","year":"2006","unstructured":"Koushik, A. et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol. Biomark. Prev. 15, 2408\u20132417 (2006).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"216_CR186","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-010-0154-4","volume":"100","author":"D Kurzwelly","year":"2010","unstructured":"Kurzwelly, D. et al. Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J. Neurooncol. 100, 187\u2013192 (2010).","journal-title":"J. Neurooncol."},{"key":"216_CR187","first-page":"133","volume":"5","author":"CM Gao","year":"2004","unstructured":"Gao, C. M. et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac. J. Cancer Prev. 5, 133\u2013138 (2004).","journal-title":"Asian Pac. J. Cancer Prev."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0216-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:53:24Z","timestamp":1720997604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0216-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":187,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0216-4","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}